Report
Debbie Wang
EUR 100.00 For Business Accounts Only

ConvaTec Makes Modest Progress on Turnaround; No Change to Our FVE

Slowly but surely, ConvaTec is making progress on its turnaround with another quarter that delivered slight improvements. Revenue growth in the first half of 2018 was largely consistent with our tempered expectations, and reported margins hit our estimates nearly on the nose. We’re leaving our fair value estimate unchanged. In terms of green shoots, we take the return of organic growth in ostomy care and 5.9% organic growth in continence care as positive signs. In particular, we think this growt...
Underlying
ConvaTec Group Plc

ConvaTec Group is a holding company. Through its subsidiaries, Co. is a global medical products and technologies group. Co. has four franchises: Advanced Wound Care, which provides wound dressings, devices and skin care products used for the management of acute and chronic wounds; Ostomy Care, which focuses on devices, accessories and services for individuals who have a stoma; Continence and Critical Care, which provides products for people with urinary continence issues; and Infusion Devices, which develops and manufactures disposable infusion sets for the suppliers of insulin pumps for diabetes treatment and similar pumps used in continuous infusion treatments for other conditions.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch